Company / R&D Expense
ICU Medical R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$87.5M
FY2025
5-year range
$42.9M / $88.6M
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#63 of 110
Health Care
What the data says
At $87M, ICU Medical's r&d expense ranks #63 of 110 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $13M in FY2018 to $89M in FY2024.
Based on SEC 10-K filings.
$87M in FY2025 with a 5-year CAGR of +10.6%.
Improved from $85M to $87M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +26.8%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
#63 of 110 in Health CareTop 57% of 110This company $87.5M Sector average $298.2M
▼
-70.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, r&d expense decreased 1.3% year-over-year.
- Ranks #63 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $87.5M | -1.3% |
| FY2024 | $88.6M | +3.8% |
| FY2023 | $85.3M | +98.7% |
| FY2022 | $42.9M | -11.6% |
| FY2021 | $48.6M | -8.1% |
| FY2020 | $52.9M | +3.1% |
| FY2019 | $51.3M | +295.6% |
| FY2018 | $13.0M | -17.6% |
| FY2017 | $15.7M | -14.3% |
| FY2016 | $18.3M | +47.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026